Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
WALD Stock Forecast 2026-2027
$1.04
Current Price
$132.11M
Market Cap
Buy 2
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to WALD Price Targets
+140.4%
To High Target of $2.50
+92.3%
To Median Target of $2.00
+53.8%
To Low Target of $1.60
WALD Price Momentum
-1.9%
1 Week Change
-11.9%
1 Month Change
-62.2%
1 Year Change
-44.7%
Year-to-Date Change
-67.7%
From 52W High of $3.22
+21.4%
From 52W Low of $0.86
📊 TOP ANALYST CALLS
Did WALD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Waldencast is one of their latest high-conviction picks.
Latest WALD Stock Price Targets & Analyst Predictions
Based on our analysis of 9 Wall Street analysts, WALD has a neutral consensus with a median price target of $2.00 (ranging from $1.60 to $2.50). The overall analyst rating is Buy (7.6/10). Currently trading at $1.04, the median forecast implies a 92.3% upside. This outlook is supported by 2 Buy, 3 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
WALD Analyst Ratings
2
Buy
3
Hold
0
Sell
WALD Price Target Range
Low
$1.60
Average
$2.00
High
$2.50
Current: $1.04
Latest WALD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for WALD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 16, 2026 | Telsey Advisory Group | Dana Telsey | Market Perform | Maintains | $2.00 |
| Mar 16, 2026 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $2.00 |
| Jan 14, 2026 | Jefferies | Sydney Wagner | Buy | Assumes | $2.00 |
| Nov 25, 2025 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $4.00 |
| Nov 25, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Downgrade | $3.00 |
| Aug 20, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $3.00 |
| Aug 13, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $4.00 |
| May 15, 2025 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $5.00 |
| May 15, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $4.00 |
| May 6, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $5.00 |
| Apr 22, 2025 | Alliance Global Partners | Aaron Grey | Buy | Initiates | $5.00 |
| Mar 20, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $5.00 |
| Mar 19, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Mar 19, 2025 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $7.50 |
| Mar 11, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Dec 16, 2024 | TD Cowen | Jonna Kim | Hold | Initiates | $4.30 |
| Dec 4, 2024 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $7.50 |
| Nov 22, 2024 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Nov 22, 2024 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $6.00 |
| Nov 18, 2024 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
Waldencast plc (WALD) Competitors
The following stocks are similar to Waldencast based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Waldencast plc (WALD) Financial Data
Valuation Metrics
Market Cap
$132.11M
Enterprise Value
$279.82M
P/E Ratio
N/A
PEG Ratio
-2.0x
Price/Sales
0.5x
Growth & Margins
Revenue Growth (YoY)
-1.7%
Gross Margin
N/A
Operating Margin
-22.5%
Net Margin
-84.4%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+24.7%
Current Ratio
1.7x
Debt/Equity
29.8x
ROE
-40.3%
ROA
-4.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Waldencast plc (WALD) Business Model
About Waldencast plc
What They Do
Invests in beauty and wellness businesses.
Business Model
Waldencast plc operates by investing in and building a portfolio of high-growth companies in the beauty and wellness sectors. The company generates revenue through strategic collaborations with emerging brands, leveraging its industry expertise and financial resources to foster growth, innovation, and sustainability.
Additional Information
Waldencast focuses on consumer-centric strategies that align with global trends in conscious consumption and well-being. By merging investment capabilities with industry insights, it acts as a catalyst for brand discovery and market expansion within the beauty and wellness industries.
Company Information
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
367
CEO
Mr. Michel Brousset
Country
United Kingdom
IPO Year
2021
Website
www.waldencast.comWaldencast plc (WALD) Latest News & Analysis
Latest News
Quick Summary
A new clinically proven formula combines NAD+ with precursors to rejuvenate skin cells and tackle nine signs of aging, promoting healthier and more resilient skin.
Why It Matters
The announcement of a clinically proven anti-aging formula could drive demand for the product, benefiting companies involved in skincare and health, potentially boosting stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
ProMD's physician-led network will engage in Obagi's ALOHA Program to evaluate MagIQ and skincare protocols across multiple states.
Why It Matters
ProMD's collaboration with Obagi enhances its service offerings, potentially increasing revenue and market share in the skincare industry, which could positively impact investor sentiment and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Waldencast reported FY 2025 net revenue of $272.1M (flat YoY) and Q4 2025 net revenue of $72.0M (flat YoY). Adjusted EBITDA was $16.1M for FY and $6.6M for Q4. The company is focusing on growth in medical aesthetics and brand expansion.
Why It Matters
Waldencast's stable revenue and strategic moves in medical aesthetics signal potential growth, while flat performance raises concerns about market competitiveness. Financial flexibility enhances growth prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Waldencast plc (NASDAQ: WALD) will release its Q4 and FY 2025 earnings on March 13, 2026, before U.S. market open, but will not hold a conference call due to a strategic review.
Why It Matters
The upcoming earnings release without a conference call may indicate uncertainty or strategic shifts at Waldencast, potentially affecting investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
It's a Secret Med Spa has been chosen as a premier luxury med spa partner, recognized for its commitment to excellence and strong patient results in its expanding network of high-end locations.
Why It Matters
The selection of It's a Secret Med Spa as a premier luxury partner highlights its market positioning and growth potential, signaling strong consumer demand in the luxury wellness sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Schweiger has been chosen as a leading dermatology platform partner for its clinical excellence and extensive national network, enhancing access to care for patients.
Why It Matters
Schweiger's selection as a leading dermatology partner enhances its market position, indicating potential growth and profitability, which can positively impact investor sentiment and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About WALD Stock
What is Waldencast plc's (WALD) stock forecast for 2026?
Based on our analysis of 9 Wall Street analysts, Waldencast plc (WALD) has a median price target of $2.00. The highest price target is $2.50 and the lowest is $1.60.
Is WALD stock a good investment in 2026?
According to current analyst ratings, WALD has 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.04. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for WALD stock?
Wall Street analysts predict WALD stock could reach $2.00 in the next 12 months. This represents a 92.3% increase from the current price of $1.04. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Waldencast plc's business model?
Waldencast plc operates by investing in and building a portfolio of high-growth companies in the beauty and wellness sectors. The company generates revenue through strategic collaborations with emerging brands, leveraging its industry expertise and financial resources to foster growth, innovation, and sustainability.
What is the highest forecasted price for WALD Waldencast plc?
The highest price target for WALD is $2.50 from at , which represents a 140.4% increase from the current price of $1.04.
What is the lowest forecasted price for WALD Waldencast plc?
The lowest price target for WALD is $1.60 from at , which represents a 53.8% increase from the current price of $1.04.
What is the overall WALD consensus from analysts for Waldencast plc?
The overall analyst consensus for WALD is neutral. Out of 9 Wall Street analysts, 2 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $2.00.
How accurate are WALD stock price projections?
Stock price projections, including those for Waldencast plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 20, 2026 10:39 PM UTC